Pharmacy benefit managers (PBMs) may be Congress’ next target for high prescription drug prices. There is evidence that PBMs may be passing too little of that savings on to customers. The traditional PBM business model creates perverse incentives for keeping prices down. Six PBMs now control 95% of the private market.
top of page
bottom of page